Slide 1: Analyst / Investor Conference Call Q1 2012 Results
Analyst / Investor Conference Call Q1 2012 Results April 12, 2012 03:00 p.m. CEST Uwe Röhrhoff, CEO Jürgen Wiecha, CFO
Slide 2: Disclaimer
Disclaimer This presentation may contain certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development
Slide 3: Agenda
Agenda Review Q1 2012 and Guidance FY 2012 Uwe Röhrhoff, CEO Financial Overview Q1 2012 Jürgen Wiecha, CFO Appendix 3
Slide 4: Q1 2012: Key figures show healthy growth
Q1 2012: Key figures show healthy growth Key group figures in EUR m, EPS in EUR Revenues adjusted EBITDA FXN: + 13.6% adjusted EBITDA Margin + 13.6% + 6.2% 17.7% 16.5% adjusted EPS Net Financial Debt + 16.2% + 6.7% 4
Slide 5: Q1 2012: Compelling revenue growth across all segments
Q1 2012: Compelling revenue growth across all segments Tubular Glass: Strong customer demand for RTF® syringes Temporary increase in quality costs Plastic Systems: Strong organic growth driven by product and tooling business Adjusted EBITDA margin reflects strong tooling revenues and hea
Slide 6: Acquisition of the market leader for MG pharma bottles in India
Acquisition of the market leader for MG pharma bottles in India Founded in 1986 by private owners Located in Mumbai, one plant in Kosamba (Gujarat) 2010/11 revenues approx. EUR 15m 600 employees Producer of moulded glass bottles for liquid and injectable medications ISO 9001:2008 certifi
Slide 7: Neutral Glass is a strategic acquisition
Neutral Glass is a strategic acquisition Leading market position Strong growth opportunities Very profitable company Strong management team Accretive in year one Further strengthens our position in emerging markets Drives our growth in India 7
Slide 8: Uplift of FY 2012 revenue guidance
Uplift of FY 2012 revenue guidance FY 2011 Original Guidance Updated Guidance3 as reported FY 2012 FY 2012 (as of Feb. 8, 2012) (as of Apr. 12, 2012) + 5% to 6% at const. FX + 7% to 8% at const. FX Revenues EUR 1,094.7m1 + 7% to 8% nominal2 + 9% to 10% nominal2 Adj. EBITDA margin 19.9% About 19.5% A
Slide 9: Agenda
Agenda Review Q1 2012 and Guidance FY 2012 Uwe Röhrhoff, CEO Financial Overview Q1 2012 Jürgen Wiecha, CFO Appendix 9
Slide 10: Q1 2012 P&L Overview
Q1 2012 P&L Overview Q1 2012 Q1 2011 Change EUR m EUR m in % Revenues 268.8 236.6 +13.6 Adjusted EBITDA1 44.3 41.8 +6.2 EBITA 21.9 21.5 +1.9 Profit before interest and taxes (EBIT) 17.4 16.8 +3.6 Financial result -7.5 -6.9 -8.7 Profit before taxes 9.9 9.9 unchanged Net income 6.8 7.1 -4.2 EPS in EUR
Slide 11: Q1 2012: Revenues by division
Q1 2012: Revenues by division Q1 2012 Change Change in % at EUR m in % const. FX Total Group 268.8 +13.6 +13.6 Tubular Glass 73.7 +10.3 +9.4 Plastic Systems 91.6 +27.1 +28.2 Moulded Glass 84.0 +4.6 +4.3 Life Science Research 23.0 +8.2 +6.5 11
Slide 12: Q1 2012: Adjusted EBITDA and margin by division
Q1 2012: Adjusted EBITDA1 and margin by division Q1 2012 Q1 2011 Change Margin Margin EUR m in % in % in % Total Group 44.3 +6.2 16.5 17.7 Tubular Glass 13.2 -4.2 17.9 20.6 Plastic Systems 17.5 +21.4 19.1 20.0 Moulded Glass 16.4 +1.8 19.5 20.1 Life Science Research 2.5 +14.7 11.1 10.4 1 Earnings bef
Slide 13: Key balance sheet figures
Key balance sheet figures Feb 29, 2012 Feb 28, 2011 Change EUR m EUR m in % Equity 571.9 536.7 +6.6 Equity ratio in % 37.8 40.2 Net Working Capital1 196.5 172.3 +14.0 in % of LTM revenues 17.4 16.6 Net Financial Debt2 369.7 318.2 +16.2 Adj. EBITDA Leverage 1.7 1.5 +13.3 Q1 2012 Q1 2011 Change EUR m
Slide 14: Long-term financing structure with ample financial leeway
Long-term financing structure with ample financial leeway Comparison of debt/cash positions in EUR m 369.7 Interest rate (due date): Net Financial Debt 318.2 300.0 Fixed coupon at 5.0% (2018) Bond 126.0 Long-term bank debt 173.4 Interest rate hedged at 3.26% 154.4 (2016) Revolving bank debt 14.3 Loc
Slide 15: Invitation to join our Capital Markets Day 2012
Invitation to join our Capital Markets Day 2012 Date July 11+12, 2012 Location Horsovsky Tyn, Czech Republic Registration gerresheimer.ir@gerresheimer.com 15
Slide 16: Financial Calendar
Financial Calendar April 26, 2012 Annual General Meeting July 11, 2012 Interim Report 2nd Quarter 2012 July 11+12, 2012 Capital Markets Day 2012 October 4, 2012 Interim Report 3rd Quarter 2012 16
Slide 17: Investor Relations & Creditor Relations contact details
Investor Relations & Creditor Relations contact details Phone +49 211 6181-257 Fax +49 211 6181-121 E-mail gerresheimer.ir@gerresheimer.com IR website www.gerresheimer.com/ir 17
Slide 18: Agenda
Agenda Review Q1 2012 and Guidance FY 2012 Uwe Röhrhoff, CEO Financial Overview Q1 2012 Jürgen Wiecha, CFO Appendix 18
Slide 19: First quarter reconciliation from adjusted EBITDA to net income
First quarter reconciliation from adjusted EBITDA to net income Q1 2012 Q1 2011 EUR m EUR m Adjusted EBITDA 44.3 41.8 One-off income/expense -2.6 -0.1 EBITDA 41.7 41.7 Amortization of fair value adjustments 4.5 4.7 Depreciation 19.8 20.2 Profit before interest and taxes (EBIT) 17.4 16.8 Financial re